Britain approves Pfizer's antiviral COVID-19 pill

Britain has approved Pfizer's Paxlovid COVID-19 pill for adults who have mild to moderate infection and are at high risk of their illness worsening, its second easily administered antiviral against the coronavirus. Britain is scrambling to build its defences amid a record surge in COVID-19 cases in the winter season as the Omicron variant of the virus spreads quickly.